GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Denali Therapeutics Inc (STU:4DN) » Definitions » Price-to-Tangible-Book

Denali Therapeutics (STU:4DN) Price-to-Tangible-Book : 1.88 (As of May. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Denali Therapeutics Price-to-Tangible-Book?

As of today (2024-05-26), Denali Therapeutics's share price is €17.63. Denali Therapeutics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €9.40. Hence, Denali Therapeutics's Price to Tangible Book Ratio of today is 1.88.

The historical rank and industry rank for Denali Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

STU:4DN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.88   Med: 4.14   Max: 8.89
Current: 1.88

During the past 9 years, Denali Therapeutics's highest Price to Tangible Book Ratio was 8.89. The lowest was 1.88. And the median was 4.14.

STU:4DN's Price-to-Tangible-Book is ranked better than
66.67% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs STU:4DN: 1.88

A closely related ratio is called PB Ratio. As of today, Denali Therapeutics's share price is €17.63. Denali Therapeutics's Book Value per Sharefor the quarter that ended in Mar. 2024 was €9.40. Hence, Denali Therapeutics's P/B Ratio of today is 1.88.


Denali Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Denali Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denali Therapeutics Price-to-Tangible-Book Chart

Denali Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only 4.33 8.67 5.54 3.59 2.89

Denali Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.18 3.36 2.59 2.89 2.03

Competitive Comparison of Denali Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Denali Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Denali Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Denali Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Denali Therapeutics's Price-to-Tangible-Book falls into.



Denali Therapeutics Price-to-Tangible-Book Calculation

Denali Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=17.63/9.396
=1.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Denali Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Denali Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Denali Therapeutics (STU:4DN) Business Description

Traded in Other Exchanges
Address
161 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Denali Therapeutics (STU:4DN) Headlines

No Headlines